Breast cancer researcher and oncologist Nancy Davidson discusses what we’ve learned from the first wave of epigenetic trials for breast cancer, and what challenges lie ahead before such therapies reach the clinic.

A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”—a yearning that can cloud our judgment.

Gottlieb will step down after two years at the helm of the US Food and Drug Administration to spend more time with his family.

In an era of instant communication, we must be careful how word of new and untested treatments is shared.

Plasmodium falciparum has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s front-line treatment.

A Novartis subsidiary is partnering with a Canadian cannabis company to sell medical marijuana worldwide.

The purchase aims to build GSK’s oncology pipeline.

This is the first time researchers have tested the use of the reprogrammed stem cells in the human brain.

The study will examine the efficacy of four drugs—an antiviral and three monoclonal antibodies—that are already being used to treat patients in Democratic Republic of Congo.